The FDA has greenlit the first human trial of ER-100, a partial epigenetic reprogramming therapy targeting age-related eye diseases, marking a pivotal step in anti-aging and regenerative medicine. A l...
Evidence-based mental fitness apps are expanding beyond meditation to include AI-driven CBT and FDA-approved digital therapeutics, addressing global mental health challenges through scalable solutions...
The FDA-approved digital therapeutics market is rapidly expanding, offering effective tools for conditions like diabetes and ADHD, supported by clinical data and growing insurance coverage. Digital th...
FDA-approved digital therapeutics are revolutionizing healthcare by integrating evidence-based apps for conditions like diabetes and mental health, enhancing treatment through real-time data and behav...
Artificial intelligence enhances breast cancer screening through improved mammography accuracy and explainable models, reducing false positives and mortality rates, as shown in recent research. Recent...
Recent pilot studies indicate BPC-157 may safely accelerate healing of tendon and muscle tears, though FDA approval is pending and WADA monitors its use in sports. Emerging research on the peptide BPC...
